ClinicalTrials.Veeva

Menu

D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients

A

Ain Shams University

Status

Completed

Conditions

Critical Illness
Pneumonia, Viral

Treatments

Other: no intervention, just observational for D-Dimer level in blood

Study type

Observational

Funder types

Other

Identifiers

NCT05279469
MS56/2022

Details and patient eligibility

About

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.

Full description

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.

It has been reported that COVID 19 is associated with hemostatic abnormalities and elevated D-Dimer level, so its level is used to predict severity of disease.

Enrollment

465 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients of both sex admitted in icu
  • positive PCR
  • requiring oxygen therapy

Exclusion criteria

  • ward patients
  • negative PCR

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems